(Q36314342)

13 August 2017

1 reference

title

A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine (English)

1 reference

13 August 2017

R Natale

1

1 reference

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

50 Suppl 1

1 reference

13 August 2017

page(s)

S2-4

1 reference

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981549-1

7 January 2021

10.1016/S0169-5002(05)81549-1

Identifiers

DOI

1 reference

13 August 2017

1 reference